FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Holly Hagan

Research Profile

Activities & Behaviors

Disorders

Organizations

Geographic Areas

Concepts & Ideas

Procedures

HIV Seroprevalence

Chemicals & Drugs

Methadone

Co-author Network

Publications

TOP 3
Don C Des Jarlais; Jonathan P Feelemyer; Abu Abdul-Quader; Shilpa N Modi; Holly Hagan
High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.
Don C Des Jarlais; Karla Gostnell; Kamyar Arasteh; Heidi Bramson; Javier Cepeda; Cherise Wong; Holly Hagan
Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis.
Don C Des Jarlais; Jonathan P Feelemyer; Kamyar Arasteh; Shilpa N Modi; Holly Hagan
Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Holly Hagan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Don C Des Jarlais; Jonathan P Feelemyer; Abu Abdul-Quader; Shilpa N Modi; Holly Hagan
High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.
BMC public health 2013;13():53.
2012: Don C Des Jarlais; Karla Gostnell; Kamyar Arasteh; Heidi Bramson; Javier Cepeda; Cherise Wong; Holly Hagan
Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis.
Addiction (Abingdon, England) 2012;107(12):2087-95.
2012: Don C Des Jarlais; Jonathan P Feelemyer; Kamyar Arasteh; Shilpa N Modi; Holly Hagan
Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas.
Drug and alcohol dependence 2012;124(1-2):95-107.
2012: Enrique R Pouget; Holly Hagan; Don C Des Jarlais
Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.
Addiction (Abingdon, England) 2012;107(6):1057-65.
2012: Don C Des Jarlais; Jonathan P Feelemyer; Kamyar Arasteh; Louisa Degenhardt; Bradley M Mathers; Shilpa N Modi; Holly Hagan
Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data.
PloS one 2012;7(3):e31227.
2011: Don C Des Jarlais; Holly Hagan; Courtney McKnight; Kamyar Arasteh; Salaam Semaan; David C Perlman
Can intranasal drug use reduce HCV infection among injecting drug users?
Drug and alcohol dependence 2011;119(3):201-6.
2011: Don C Des Jarlais; Holly Hagan; Courtney McKnight; David C Perlman; Kamyar Arasteh; Salaam Semaan
Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.
American journal of public health 2011;101(7):1277-83.
2011: Lydia N Drumright; Richard S Garfein; Elizabeth T Golub; Holly Hagan; Farzana Kapadia; Mary H Latka; Sebastian Bonner; Jennifer V Campbell; John D Clapp; Thelma King Thiel; David L Thomas; Steffanie A Strathdee
Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention.
Journal of hepatology 2011;55(1):45-52.
2011: Camila Gelpí-Acosta; Holly Hagan; Samuel M Jenness; Travis Wendel; Alan Neaigus
Sexual and injection-related risks in Puerto Rican-born injection drug users living in New York City: A mixed-methods analysis.
Harm reduction journal 2011;8():28.
2010: Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; David C Perlman; Holly Hagan; Salaam Semaan; Samuel R Friedman
Gender and age patterns in HSV-2 and HIV infection among non-injecting drug users in New York City.
Sexually transmitted diseases 2010;37(10):637-43.
2010: Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Lucia V Torian; Sara Beatice; Salaam Semaan; Samuel R Friedman
HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.
Drug and alcohol dependence 2010;109(1-3):154-60.
2010: Lara S Coffin; Ashley Newberry; Holly Hagan; Charles M Cleland; Don C Des Jarlais; David C Perlman
Syphilis in drug users in low and middle income countries.
The International journal on drug policy 2010;21(1):20-7.
2009: Don C Des Jarlais; Kamyar Arasteh; Holly Hagan; Courtney McKnight; David C Perlman; Samuel R Friedman
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.
American journal of public health 2009;99 Suppl 2():S445-51.
2009: Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Samuel R Friedman
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Drug and alcohol dependence 2009;101(1-2):88-91.
2009: Corina Lelutiu-Weinberger; Enrique R Pouget; Don C Des Jarlais; Hannah L Cooper; Roberta Scheinmann; Rebecca Stern; Shiela M Strauss; Holly Hagan
A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.
Social science & medicine (1982) 2009;68(3):579-90.
2008: Don C Des Jarlais; Kamyar Arasteh; Holly Hagan
Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;179(11):1105-6.
2008: Holly Hagan; Enrique R Pouget; Don C Des Jarlais; Corina Lelutiu-Weinberger
Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.
American journal of epidemiology 2008;168(10):1099-109.
2008: Mary H Latka; Holly Hagan; Farzana Kapadia; Elizabeth T Golub; Sebastian Bonner; Jennifer V Campbell; Micaela H Coady; Richard S Garfein; Minya Pu; David L Thomas; Thelma K Thiel; Steffanie A Strathdee
A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C.
American journal of public health 2008;98(5):853-61.
2008: Corrine E Munoz-Plaza; Shiela Strauss; Janetta Astone-Twerell; Don C Des Jarlais; Marya Gwadz; Holly Hagan; Andrew Osborne; Andrew Rosenblum
Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.
The International journal on drug policy 2008;19(1):71-8.
2008: Rebecca K Stern; Holly Hagan; Corina Lelutiu-Weinberger; Don C Des Jarlais; Roberta Scheinmann; Shiela Strauss; Enrique R Pouget; Peter Flom
The HCV Synthesis Project: scope, methodology, and preliminary results.
BMC medical research methodology 2008;8():62.
2008: Samuel R Friedman; Pedro Mateu-Gelabert; Milagros Sandoval; Holly Hagan; Don C Des Jarlais
Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection.
BMC public health 2008;8():94.
2007: Don C Des Jarlais; Holly Hagan; Kamyar Arasteh; Courtney McKnight; David C Perlman; Samuel R Friedman
Herpes simplex virus-2 and HIV among noninjecting drug users in New York city.
Sexually transmitted diseases 2007;34(11):923-7.
2007: Richard S Garfein; Andrea Swartzendruber; Lawrence J Ouellet; Farzana Kapadia; Sharon M Hudson; Hanne Thiede; Steffanie A Strathdee; Ian T Williams; Susan L Bailey; Holly Hagan; Elizabeth T Golub; Peter R Kerndt; Debra L Hanson; Mary H Latka
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Drug and alcohol dependence 2007;91 Suppl 1():S4-17.
2007: Hanne Thiede; Holly Hagan; Jennifer V Campbell; Steffanie A Strathdee; Susan L Bailey; Sharon M Hudson; Farzana Kapadia; Richard S Garfein
Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities.
Drug and alcohol dependence 2007;91 Suppl 1():S39-47.
2007: Susan L Bailey; Lawrence J Ouellet; Mary Ellen Mackesy-Amiti; Elizabeth T Golub; Holly Hagan; Sharon M Hudson; Mary H Latka; Weihua Gao; Richard S Garfein
Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities.
Drug and alcohol dependence 2007;91 Suppl 1():S18-29.
2007: Elizabeth T Golub; Steffanie A Strathdee; Susan L Bailey; Holly Hagan; Mary H Latka; Sharon M Hudson; Richard S Garfein
Distributive syringe sharing among young adult injection drug users in five U.S. cities.
Drug and alcohol dependence 2007;91 Suppl 1():S30-8.
2007: Holly Hagan; Jennifer V Campbell; Hanne Thiede; Steffanie A Strathdee; Lawrence J Ouellet; Mary H Latka; Sharon Hudson; Richard S Garfein
Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior.
Drug and alcohol dependence 2007;91 Suppl 1():S48-55.
2007: Jennifer V Campbell; Richard S Garfein; Hanne Thiede; Holly Hagan; Lawrence J Ouellet; Elizabeth T Golub; Sharon M Hudson; Danielle C Ompad; Cindy Weinbaum
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
Drug and alcohol dependence 2007;91 Suppl 1():S64-72.
2007: Holly Hagan; Don C Des Jarlais; Rebecca Stern; Corina Lelutiu-Weinberger; Roberta Scheinmann; Shiela Strauss; Peter L Flom
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.
The International journal on drug policy 2007;18(5):341-51.
2007: Richard S Garfein; Elizabeth T Golub; Alan E Greenberg; Holly Hagan; Debra L Hanson; Sharon M Hudson; Farzana Kapadia; Mary H Latka; Lawrence J Ouellet; David W Purcell; Steffanie A Strathdee; Hanne Thiede
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
AIDS (London, England) 2007;21(14):1923-32.
2007: Roberta Scheinmann; Holly Hagan; Corina Lelutiu-Weinberger; Rebecca Stern; Don C Des Jarlais; Peter L Flom; Shiela Strauss
Non-injection drug use and Hepatitis C Virus: a systematic review.
Drug and alcohol dependence 2007;89(1):1-12.
2007: Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Samuel R Friedman
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
Addiction (Abingdon, England) 2007;102(5):778-85.
2007: Richard D Burt; Holly Hagan; Richard S Garfein; Keith Sabin; Cindy Weinbaum; Hanne Thiede
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Journal of urban health : bulletin of the New York Academy of Medicine 2007;84(3):436-54.
2007: Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu S Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
AIDS (London, England) 2007;21(2):231-5.
2007: Shiela M Strauss; Janetta M Astone-Twerell; Corrine Munoz-Plaza; Don C Des Jarlais; Marya Gwadz; Holly Hagan; Andrew Osborne; Andrew Rosenblum
Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needs.
The American journal of drug and alcohol abuse 2007;33(2):245-51.
2007: Shiela M Strauss; Janetta M Astone-Twerell; Corrine Munoz-Plaza; Don C Des Jarlais; Marya Gwadz; Holly Hagan; Andrew Osborne; Andrew Rosenblum
Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.
BMC health services research 2007;7():39.
2007: Farzana Kapadia; Mary H Latka; Holly Hagan; Elizabeth T Golub; Jennifer V Campbell; Micaela H Coady; Richard S Garfein; David L Thomas; Sebastian Bonner; Thelma Thiel; Steffanie A Strathdee
Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE).
Journal of urban health : bulletin of the New York Academy of Medicine 2007;84(1):99-115.
2006: Holly Hagan; Jennifer Campbell; Hanne Thiede; Steffanie A Strathdee; Lawrence J Ouellet; Farzana Kapadia; Sharon Hudson; Richard S Garfein
Self-reported hepatitis C virus antibody status and risk behavior in young injectors.
Public health reports (Washington, D.C. : 1974) 2006;121(6):710-9.
2006: Corrine Munoz-Plaza; Shiela M Strauss; Janetta M Astone-Twerwll; Don C Des Jarlais; Holly Hagan
Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs.
Journal of psychoactive drugs 2006;38(3):233-41.
2006: Zdravko P Vassilev; Holly Hagan; A Lyubenova; N Tomov; G Vasilev; D Krasteva; Don C Des Jarlais
Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
International journal of STD & AIDS 2006;17(9):621-6.
2006: Ryan J Deibert; Gary M Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.
American journal of public health 2006;96(8):1347-53.
2006: Shiela M Strauss; David M Rindskopf; Janetta M Astone-Twerell; Don C Des Jarlais; Holly Hagan
Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.
Drug and alcohol dependence 2006;83(1):15-24.
2006: Holly Hagan; Mary H Latka; Jennifer V Campbell; Elizabeth T Golub; Richard S Garfein; David A Thomas; Farzana Kapadia; Steffanie A Strathdee
Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(5):669-72.
2006: Jennifer V Campbell; Holly Hagan; Mary H Latka; Richard S Garfein; Elizabeth T Golub; Micaela H Coady; David L Thomas; Steffanie A Strathdee
High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities.
Drug and alcohol dependence 2006;81(3):259-65.
2006: Shiela M Strauss; Janetta M Astone-Twerell; Corrine Munoz-Plaza; Don C Des Jarlais; Marya Gwadz; Holly Hagan; Andrew Osborne; Andrew Rosenblum
Hepatitis C knowledge among staff in U.S. drug treatment programs.
Journal of drug education 2006;36(2):141-58.
2006: Joseph Raymond Zunt; Ken Tapia; Hanne Thiede; Rong Lee; Holly Hagan
HTLV-2 infection in injection drug users in King County, Washington.
Scandinavian journal of infectious diseases 2006;38(8):654-63.
2005: Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Holly Hagan; Sara Beatrice; Lou Smith; Judith Wethers; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
AIDS (London, England) 2005;19 Suppl 3():S20-5.
2005: Holly Hagan; Hanne Thiede; Don C Des Jarlais
HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.
AIDS (London, England) 2005;19 Suppl 3():S199-207.
2005: Steffanie A Strathdee; Mary H Latka; J Campbell; P T O'Driscoll; Elizabeth T Golub; Farzana Kapadia; Robin A Pollini; Richard S Garfein; David L Thomas; Holly Hagan
Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40 Suppl 5():S304-12.
2005: Holly Hagan; Shiela M Strauss; Janetta M Astone; Don C Des Jarlais
Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40 Suppl 5():S297-303.
2005: Shiela M Strauss; Janetta M Astone; Don C Des Jarlais; Holly Hagan
Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
AIDS patient care and STDs 2005;19(2):78-88.
2005: Shiela M Strauss; Janetta M Astone; Corrine Munoz-Plaza; Holly Hagan; Don C Des Jarlais
Residential substance user treatment programs as venues for HCV pharmacological treatment: client and staff perspectives.
Substance use & misuse 2005;40(12):1811-29.
2004: Janetta M Astone; Shiela M Strauss; Holly Hagan; Don C Des Jarlais
Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
The American journal of drug and alcohol abuse 2004;30(4):783-97.
2004: Holly Hagan; Hanne Thiede; Don C Des Jarlais
Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion.
Epidemiology (Cambridge, Mass.) 2004;15(5):543-9.
2004: Zdravko P Vassilev; Holly Hagan
Highly active antiretroviral therapy for injection drug users: physician-recommended strategies for enhanced adherence.
Antiviral therapy 2004;9(3):461.
2004: Elizabeth T Golub; Mary H Latka; Holly Hagan; Jennifer Havens; Sharon M Hudson; Farzana Kapadia; Jennifer V Campbell; Richard S Garfein; David L Thomas; Steffanie A Strathdee
Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory.
Journal of urban health : bulletin of the New York Academy of Medicine 2004;81(2):278-90.
2004: Shiela M Strauss; Janetta M Astone; Don C Des Jarlais; Holly Hagan
A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.
Drug and alcohol dependence 2004;73(3):227-36.
2004: Shiela M Strauss; Janetta M Astone; Holly Hagan; Don C Des Jarlais
The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units.
Journal of urban health : bulletin of the New York Academy of Medicine 2004;81(1):38-47.
2004: Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Holly Hagan; Judith Milliken; Naomi Braine; Stanley Yancovitz; Donna Mildvan; David C Perlman; Carey Maslow; Samuel R Friedman
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
Journal of acquired immune deficiency syndromes (1999) 2004;35(2):158-66.
2003: Hanne Thiede; Linda A Valleroy; Duncan MacKellar; David Celentano; Wesley L Ford; Holly Hagan; Beryl A Koblin; Marlene LaLota; Willi McFarland; Douglas Shehan; Lucia V Torian
Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas.
American journal of public health 2003;93(11):1915-21.
2003: Holly Hagan; Hanne Thiede
Does bleach disinfection of syringes help prevent hepatitis C virus transmission?
Epidemiology (Cambridge, Mass.) 2003;14(5):628-9; author reply 629.
2003: Shiela M Strauss; Janetta M Astone; Zdravko P Vassilev; Don C Des Jarlais; Holly Hagan
Gaps in the drug-free and methadone treatment program response to Hepatitis C.
Journal of substance abuse treatment 2003;24(4):291-7.
2003: Thomas Perdue; Holly Hagan; Hanne Thiede; Linda A Valleroy
Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men.
AIDS education and prevention : official publication of the International Society for AIDS Education 2003;15(1):81-92.
2002: Holly Hagan; Nadine Snyder; Eileen Hough; Tianji Yu; Shelly McKeirnan; Janice Boase; Jeffrey S Duchin
Case-reporting of acute hepatitis B and C among injection drug users.
Journal of urban health : bulletin of the New York Academy of Medicine 2002;79(4):579-85.
2002: Holly Hagan; Hanne Thiede; James P McGough; E Russell Alexander
Hepatitis B vaccination among research participants, Seattle, Washington.
American journal of public health 2002;92(11):1756.
2002: Sherry Deren; Michele G Shedlin; Thomas Hamilton; Holly Hagan
Impact of the September 11th attacks in New York City on drug users: a preliminary assessment.
Journal of urban health : bulletin of the New York Academy of Medicine 2002;79(3):409-12.
2001: Hanne Thiede; M Romero; K Bordelon; Holly Hagan; C S Murrill
Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users.
Journal of urban health : bulletin of the New York Academy of Medicine 2001;78(2):264-78.
2001: P T O'Driscoll; James P McGough; Holly Hagan; Hanne Thiede; C Critchlow; E Russell Alexander
Predictors of accidental fatal drug overdose among a cohort of injection drug users.
American journal of public health 2001;91(6):984-7.
2001: Holly Hagan; Hanne Thiede; NS Weiss; Sharon G Hopkins; Jeffrey S Duchin; E Russell Alexander
Sharing of drug preparation equipment as a risk factor for hepatitis C.
American journal of public health 2001;91(1):42-6.
2000: Holly Hagan; James P McGough; Hanne Thiede; S Hopkins; Jeffrey S Duchin; E Russell Alexander
Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors.
Journal of substance abuse treatment 2000;19(3):247-52.
2000: Holly Hagan; Hanne Thiede
Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.
Journal of urban health : bulletin of the New York Academy of Medicine 2000;77(3):369-82.
2000: Hanne Thiede; Holly Hagan; C S Murrill
Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.
Journal of urban health : bulletin of the New York Academy of Medicine 2000;77(3):331-45.
2000: Holly Hagan; James P McGough; Hanne Thiede; Sharon G Hopkins; NS Weiss; E Russell Alexander
Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs.
Journal of urban health : bulletin of the New York Academy of Medicine 2000;77(1):103-12.
2000: Holly Hagan
Vaccination could improve overall health in a high risk population.
The Western journal of medicine 2000;172(1):21.
1999: Don C Des Jarlais; Denise Paone; Judith Milliken; Charles F Turner; H Miller; James N Gribble; Q Shi; Holly Hagan; Samuel R Friedman
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial.
Lancet 1999;353(9165):1657-61.
1999: Holly Hagan; James P McGough; Hanne Thiede; NS Weiss; S Hopkins; E Russell Alexander
Syringe exchange and risk of infection with hepatitis B and C viruses.
American journal of epidemiology 1999;149(3):203-13.
1997: Don C Des Jarlais; Samuel R Friedman; Holly Hagan; Denise Paone; David Vlahov
Drug use. Vancouver Conference Review.
AIDS care 1997;9(1):53-7.
1996: Don C Des Jarlais; Patricia Friedmann; Holly Hagan; Samuel R Friedman
The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use.
American journal of public health 1996;86(12):1780-5.
1995: Don C Des Jarlais; Holly Hagan; Samuel R Friedman; Patricia Friedmann; D Goldberg; M Frischer; S Green; K Tunving; B Ljungberg; A Wodak
Maintaining low HIV seroprevalence in populations of injecting drug users.
JAMA : the journal of the American Medical Association 1995;274(15):1226-31.